Multiplex and High-throughput Mass Spectrometry Immunoassay Based on Element Labeling Strategy
Gongwei Sun,Weiliang Liu,Jinhui Liu,Linfeng Sheng,Zhi Xing,Sichun Zhang,Xinrong Zhang
DOI: https://doi.org/10.46770/as.2023.279
2023-01-01
Atomic Spectroscopy
Abstract:Inductively coupled plasma mass spectrometry (ICP-MS) has emerged as a potential analytical platform for clinical detection of biomarkers based on element labeling strategy. However, it is challenging to achieve the routine analysis in clinical laboratory due to the platform's low throughput, low degree of automation, and lack of supporting reagents. Here, we developed a multiplex, high-throughput and automatic immunoassay platform based on rare earth elements (REEs) labeling strategy coupled with ICP-MS detection. On the platform, washing, sampling, rapid uptake and detecting were all automated after manually adding samples. The total time of the entire process can be completed in 40 min. To verify the analytical performance of the platform, the lung cancer five-index immunoassay kits of CEA, CYFRA21-1, NSE, SCC and ProGRP were used as a model. All analytical properties including detection limits, linear range, accuracy, precision, and anti-interference meet the needs of clinical detection. Besides, 350 clinical serum samples were used to validate the platform's potential for clinical application. The developed MSbased immunoassay platform will play an important role for clinical multiplex detection in the fields of cancer, cytokines, and autoimmunity.